Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberly B Hashemi

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
JAAD Case Reports|July 14, 2021
Morpheaform sarcoidosis: A case presentation of an uncommon cutaneous manifestation of sarcoidosisKimberly B Hashemi, Jamie C Latos, Faye N Hant
JAAD Case Reports|March 14, 2022
Ragged cuticles and erythematous hands and feet in a pediatric patient with chronic diarrheaAndraia R Li, Kimberly B Hashemi, Katherine Silver, et al.
Dermatologic Clinics|November 14, 2024
Innovation in DermatomyositisKimberly B Hashemi, Katharina S Shaw, Rochelle Castillo, et al.
JAAD Case Reports|December 22, 2022
A case of nivolumab-induced scleroderma-like syndrome successfully treated with intravenous immunoglobulinAlexa DeMaio, Kimberly B Hashemi, Alexandria Avery, et al.
JAMA Dermatology|November 11, 2023
Rapid Improvement in Recalcitrant Cutaneous Juvenile Dermatomyositis With Anifrolumab TreatmentKatharina S Shaw, Diana B Reusch, Rochelle L Castillo, et al.
Journal of the American Academy of Dermatology|December 21, 2023
Depression in patients with Raynaud's phenomenon: A case-control study in the National Institutes of Health's All of Us Research ProgramGloria F Chen, Katharina S Shaw, Suzanne Xu, et al.
Transplantation Proceedings|October 14, 2023
Oral Nicotinamide for Actinic Keratosis Prevention in Kidney Transplant Recipients: A Pilot Double-Blind, Randomized, Placebo-Controlled TrialHelen Zhang, Elisabeth A George-Washburn, Kimberly B Hashemi, et al.
Journal of the American Academy of Dermatology|August 14, 2024
Anifrolumab in recalcitrant cutaneous dermatomyositis: A multicenter retrospective cohort studyKatharina S Shaw, Kimberly B Hashemi, Rochelle L Castillo, et al.
Clinical and Experimental Dermatology|November 20, 2024
Three-dimensional stereophotogrammetry: an effective tool for detecting disease progression in lupus erythematosus panniculitisKimberly B Hashemi, Laura I Ortiz-López, Karla M Santiago-Soltero, et al.
The British Journal of Dermatology|April 27, 2024
De novo autoimmune connective tissue disease and mortality in patients treated with anti-programmed death receptor-1 and anti-programmed death-ligand 1 therapy: a population-level cohort studyKimberly Tang, Ahmad Rajeh, Katharina S Shaw, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
JAAD Case Reports|July 14, 2021
Morpheaform sarcoidosis: A case presentation of an uncommon cutaneous manifestation of sarcoidosisKimberly B Hashemi, Jamie C Latos, Faye N Hant
JAAD Case Reports|March 14, 2022
Ragged cuticles and erythematous hands and feet in a pediatric patient with chronic diarrheaAndraia R Li, Kimberly B Hashemi, Katherine Silver, et al.
Dermatologic Clinics|November 14, 2024
Innovation in DermatomyositisKimberly B Hashemi, Katharina S Shaw, Rochelle Castillo, et al.
JAAD Case Reports|December 22, 2022
A case of nivolumab-induced scleroderma-like syndrome successfully treated with intravenous immunoglobulinAlexa DeMaio, Kimberly B Hashemi, Alexandria Avery, et al.
JAMA Dermatology|November 11, 2023
Rapid Improvement in Recalcitrant Cutaneous Juvenile Dermatomyositis With Anifrolumab TreatmentKatharina S Shaw, Diana B Reusch, Rochelle L Castillo, et al.
Journal of the American Academy of Dermatology|December 21, 2023
Depression in patients with Raynaud's phenomenon: A case-control study in the National Institutes of Health's All of Us Research ProgramGloria F Chen, Katharina S Shaw, Suzanne Xu, et al.
Transplantation Proceedings|October 14, 2023
Oral Nicotinamide for Actinic Keratosis Prevention in Kidney Transplant Recipients: A Pilot Double-Blind, Randomized, Placebo-Controlled TrialHelen Zhang, Elisabeth A George-Washburn, Kimberly B Hashemi, et al.
Journal of the American Academy of Dermatology|August 14, 2024
Anifrolumab in recalcitrant cutaneous dermatomyositis: A multicenter retrospective cohort studyKatharina S Shaw, Kimberly B Hashemi, Rochelle L Castillo, et al.
Clinical and Experimental Dermatology|November 20, 2024
Three-dimensional stereophotogrammetry: an effective tool for detecting disease progression in lupus erythematosus panniculitisKimberly B Hashemi, Laura I Ortiz-López, Karla M Santiago-Soltero, et al.
The British Journal of Dermatology|April 27, 2024
De novo autoimmune connective tissue disease and mortality in patients treated with anti-programmed death receptor-1 and anti-programmed death-ligand 1 therapy: a population-level cohort studyKimberly Tang, Ahmad Rajeh, Katharina S Shaw, et al.
Pageof 1